CQUniversity
Browse

Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome

journal contribution
posted on 2018-10-04, 00:00 authored by Paul NeilsenPaul Neilsen, JE Noll, RJ Suetani, RB Schulz, F Al-Ejeh, A Evdokiou, DP Lane, DF Callen
Mutations in the TP53 gene commonly result in the expression of a full-length protein that drives cancer cell invasion and metastasis. Herein, we have deciphered the global landscape of transcriptional regulation by mutant p53 through the application of a panel of isogenic H1299 derivatives with inducible expression of several common cancer-associated p53 mutants. We found that the ability of mutant p53 to alter the transcriptional profile of cancer cells is remarkably conserved across different p53 mutants. The mutant p53 transcriptional landscape was nested within a small subset of wild-type p53 responsive genes, suggesting that the oncogenic properties of mutant p53 are conferred by retaining its ability to regulate a defined set of p53 target genes. These mutant p53 target genes were shown to converge upon a p63 signalling axis. Both mutant p53 and wild-type p63 were co-recruited to the promoters of these target genes, thus providing a molecular basis for their selective regulation by mutant p53. We demonstrate that mutant p53 manipulates the gene expression pattern of cancer cells to facilitate invasion through the release of a pro-invasive secretome into the tumor microenvironment. Collectively, this study provides mechanistic insight into the complex nature of transcriptional regulation by mutant p53 and implicates a role for tumor-derived p53 mutations in the manipulation of the cancer cell secretome. © Neilsen et al.

Funding

Category 1 - Australian Competitive Grants (this includes ARC, NHMRC)

History

Volume

2

Issue

12

Start Page

1203

End Page

1217

Number of Pages

15

eISSN

1949-2553

Publisher

Impact Journals LLC

Peer Reviewed

  • Yes

Open Access

  • Yes

External Author Affiliations

University of Adelaide; Signal Transduction Laboratory; p53Lab, Immunos, Agency for Science, Technology and Research;

Era Eligible

  • Yes

Journal

Oncotarget

Usage metrics

    CQUniversity

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC